Prosecution Insights
Prosecution Insights
16 pending office actions • 13 art units • 16 examiners • 0 of 16 (0%) have an AI response strategy ready • 33 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 12 (75%) |
| §102 only | 1 (6%) |
| §112 only | 2 (12%) |
| No statute on record | 1 (6%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAHAKIS, MANOLIS Y | 1 | 68.9% | +49.8% |
| PARK, EDWARD | 1 | 82.1% | +18.0% |
| JAFFRI, ZEHRA | 1 | 62.8% | +46.6% |
| JOHNSON, NICOLE F | 1 | 87.4% | +7.1% |
| ENGLISH, CONNOR KENNEDY | 1 | 55.3% | +54.8% |
| CHATTIN, AMY MARIE | 1 | 71.8% | +42.3% |
| DANIEL, ANTARIUS S | 1 | 52.7% | +16.0% |
| DUFFY, BRADLEY | 1 | 54.6% | +45.3% |
| CORNET, JEAN P | 1 | 42.0% | +47.7% |
| GILL, RACHEL B | 1 | 65.5% | +28.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18599646 | STABILIZING FRAMES AND METHODS OF POSITIONING WITH A STABILIZING FRAME | JOHNSON, NICOLE F | 8d |
| 18667194 | 3D QUANTITATIVE JOINT MUSCLE EVALUATION VIA AUTOMATED JOINT MUSCLE SEGMENTATION WITH ARTIFICIAL INTELLIGENCE | PARK, EDWARD | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18040531 | MULTI-EPITOPE VACCINE | GILL, RACHEL B | 24d overdue |
| 18169293 | AMHR2-ED CANCER VACCINE FORMULATIONS | DUFFY, BRADLEY | 23d overdue |
| 18713215 | SYSTEM AND PROCESS FOR CLOSED-LOOP DEEP BRAIN STIMULATION | PAHAKIS, MANOLIS Y | 12d |
| 18546245 | TREATING VIRAL INFECTION WITH NMD INHIBITORS | ENGLISH, CONNOR KENNEDY | 12d |
| 18041249 | BACE1 INHIBITOR TREATMENT FOR SUPPRESSING CYTOKINE STORM | CORNET, JEAN P | 60d |
| 18667194 | 3D QUANTITATIVE JOINT MUSCLE EVALUATION VIA AUTOMATED JOINT MUSCLE SEGMENTATION WITH ARTIFICIAL INTELLIGENCE | PARK, EDWARD | — |
| 18659920 | METHOD AND APPARATUSES FOR ACCESSING AND/OR MODIFYING A TARGET PATIENT TISSUE SITE | JAFFRI, ZEHRA | — |
| 18252928 | ANTI-CD6 ANTIBODY CONJUGATES FOR TREATING T-CELL MEDIATED DISORDERS AND T-CELL LYMPHOMA/LEUKEMIA | CHATTIN, AMY MARIE | — |
| Art Unit | Apps |
|---|---|
| 3796 | 2 |
| 1643 | 2 |
| 3783 | 2 |
| 2675 | 1 |
| 3771 | 1 |
| 1625 | 1 |
| 1628 | 1 |
| 1671 | 1 |
| 1626 | 1 |
| 3797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18713215 | SYSTEM AND PROCESS FOR CLOSED-LOOP DEEP BRAIN STIMULATION | PAHAKIS, MANOLIS Y | 3796 | §103 | Non-Final OA | 12d | Pending | May 24, 2024 |
| 18667194 | 3D QUANTITATIVE JOINT MUSCLE EVALUATION VIA AUTOMATED JOINT MUSCLE SEGMENTATION WITH ARTIFICIAL INTELLIGENCE | PARK, EDWARD | 2675 | §103 | Non-Final OA | — | Pending | May 17, 2024 |
| 18659920 | METHOD AND APPARATUSES FOR ACCESSING AND/OR MODIFYING A TARGET PATIENT TISSUE SITE | JAFFRI, ZEHRA | 3771 | §112 | Non-Final OA | — | Pending | May 09, 2024 |
| 18599646 | STABILIZING FRAMES AND METHODS OF POSITIONING WITH A STABILIZING FRAME | JOHNSON, NICOLE F | 3796 | §102 | Non-Final OA | 8d | Pending | Mar 08, 2024 |
| 18546245 | TREATING VIRAL INFECTION WITH NMD INHIBITORS | ENGLISH, CONNOR KENNEDY | 1625 | §103 | Non-Final OA | 12d | Pending | Aug 11, 2023 |
| 18252928 | ANTI-CD6 ANTIBODY CONJUGATES FOR TREATING T-CELL MEDIATED DISORDERS AND T-CELL LYMPHOMA/LEUKEMIA | CHATTIN, AMY MARIE | 1643 | §112 | Non-Final OA | — | Pending | May 15, 2023 |
| 18111138 | PROTECTIVE COVER | DANIEL, ANTARIUS S | 3783 | §103 | Final Rejection | — | Pending | Feb 17, 2023 |
| 18169293 | AMHR2-ED CANCER VACCINE FORMULATIONS | DUFFY, BRADLEY | 1643 | Other | Non-Final OA | 23d overdue | Pending | Feb 15, 2023 |
| 18041249 | BACE1 INHIBITOR TREATMENT FOR SUPPRESSING CYTOKINE STORM | CORNET, JEAN P | 1628 | §103 | Final Rejection | 60d | Pending | Feb 10, 2023 |
| 18040531 | MULTI-EPITOPE VACCINE | GILL, RACHEL B | 1671 | §103 | Non-Final OA | 24d overdue | Pending | Feb 03, 2023 |
| 18001832 | TREATMENT OF VIRAL INFECTIONS WITH ESTROGEN RECEPTOR MODULATORS AND ANTI-INFLAMMATORY AGENTS | HAVLIN, ROBERT H | 1626 | §103 | Final Rejection | 45d overdue | Pending | Dec 14, 2022 |
| 17927536 | AMBULATORY FLUID DRAINAGE AND COLLECTION DEVICE | FREDRICKSON, COURTNEY B | 3783 | §103 | Non-Final OA | 33d | Pending | Nov 23, 2022 |
| 17854597 | RADIOPAQUE TISSUE MARKER | TALTY, MARIA CHRISTINA | 3797 | §103 | Final Rejection | — | Pending | Jun 30, 2022 |
| 17488384 | RAPID TEST SYSTEM FOR VIRAL AND BACTERIAL INFECTIONS | JADHAO, SAMADHAN JAISING | 1672 | §103 | Non-Final OA | 12d | Pending | Sep 29, 2021 |
| 17281324 | METHOD FOR DIAGNOSING CLOSTRIDIOIDES DIFFICILE INFECTION | PORTILLO, JAIRO H | 3791 | §103 | Final Rejection | — | Pending | Mar 30, 2021 |
| 16982090 | THERMORESPONSIVE COMPOSITIONS AND METHODS FOR PREVENTING AND DISRUPTING BIOFILMS | WRIGHT, SARAH C | 1619 | §103 | Non-Final OA | — | Pending | Sep 18, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial